Table 5.

Associations Between Prenatal Care Indicators and Preterm Delivery

Entire SampleTerm DeliveryPreterm DeliveryP valuePreterm OR95% CI
Pregnancy intention (n = 549)0.72*
 Intended (REF)331229 (69.2)102 (30.8)------
 Unintended218154 (70.6)64 (29.4)0.930.64-1.36
Prenatal intake visit (n = 660)0.61*
 Intake visit <12 wks gestation (REF)567381 (67.2)186 (32.8)------
 No intake visit <12 wks gestation9360 (64.5)33 (35.5)1.130.71-1.78
Multivitamin use (n = 169)0.17*
 ≥3 Months of prenatal use (REF)9651 (53.1)45 (46.9)------
 <3 Months of prenatal use7331 (42.5)42 (57.5)1.540.83-2.84
Tobacco avoidance (n = 653)0.80*
 Yes (REF)583391 (67.1)192 (32.9)------
 No7048 (68.6)22 (31.4)0.930.55-1.59
Depression screening (n = 542)0.68*
 Negative (REF)482341 (70.7)141 (29.3)------
 Positive6044 (73.3)16 (26.7)0.880.48-1.61
BMI (n = 647)<0.001*
 BMI >18 and <30 (REF)374274 (73.3)100 (26.7)------
 BMI ≤18 and ≥30273163 (59.7)110 (40.3)1.851.33-2.58
STI screening (n = 622)0.07*
 Negative (REF)604422 (69.9)182 (30.1)------
 Positive189 (50.0)9 (50.0)2.320.91-5.94
A1c goal (n = 59)0.07*
 <6.5 (REF)4322 (51.2)21 (48.8)------
 ≥6.5164 (25.0)12 (75.0)3.140.87-11.30
Teratogenic medication use (n = 661)0.33
 No (REF)660440 (66.7)220 (33.3)------
 Yes10 (0.0)1 (100.0)n/an/a
Blood pressure (n = 634)0.002*
 <120/80 (REF)364264 (72.5)100 (27.5)------
 ≥120/80270165 (61.1)105 (38.9)1.681.20-2.35
Harmful drug use (n = 653)0.69*
 Avoided harmful substances (REF)604402 (66.6)202 (33.4)------
 Use of harmful substances4934 (69.4)15 (30.6)0.880.47-1.65
  • * Chi-square test-of-independence.

  • Fisher’s Exact test. Highlighted values indicate statistical significance.

  • Abbreviations: OR, Odds ratio; CI, Confidence interval; REF, Reference; Wks, Weeks; BMI, Body mass index; STI, Sexually transmitted infection.